Christopher Krawtschuk's most recent trade in Bluebird bio Inc was a trade of 199,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bluebird bio Inc | Christopher Krawtschuk | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Christopher Krawtschuk | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 06 Dec 2023 | 4,526 | 45,474 (0%) | 0% | 4.5 | 20,437 | Common Stock |
Bluebird bio Inc | Christopher Krawtschuk | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 100,000 | 100,000 | - | - | Stock Options (Right to buy) | |
Bluebird bio Inc | Christopher Krawtschuk | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock |